Clinical Trial Update: Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 Diabetes

View source ↗

Summary

This clinical trial update reports the completion of an observational study evaluating the effectiveness and safety of Levemir, NovoMix 30, and NovoRapid in ins…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)
• NovoMix 30 (insulin aspart protamine fixed-dose combination)
• NovoRapid (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED